Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline

Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline

<p><strong>Introduction:</strong> Less-invasive surfactant administration (LISA) is a method of surfactant delivery to preterm infants for treating respiratory distress syndrome (RDS), which can reduce the composite risk of death or bronchopulmonary dysplasia and the time on mechan...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Reynolds, P, Bustani, P, Darby, C, Fernandez Alvarez, JR, Fox, G, Jones, S, Robertson, SJ, Vasu, V, Roehr, CC
Materialtyp:	Journal article
Språk:	English
Publicerad:	Karger Publishers 2021

Liknande verk

Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress
av: Ramaswamy, VV, et al.
Publicerad: (2021)

Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress syndrome treated with noninvasive respiratory support
av: Ramaswamy, VV, et al.
Publicerad: (2021)

To sedate or not to sedate for less invasive surfactant administration: an ethical approach
av: Peterson, J, et al.
Publicerad: (2021)

Curriculum and assessment tool for less invasive surfactant administration: an international Delphi consensus study
av: Breindahl, N, et al.
Publicerad: (2023)

Guidelines for the use of lung ultrasound to optimise the management of neonatal respiratory distress: international expert consensus
av: Jing Liu, et al.
Publicerad: (2025-02-01)

Efficacy of non‐invasive respiratory support modes for primary respiratory support in preterm neonates with Respiratory Distress Syndrome: Systematic review and network meta‐analysis
av: Ramaswamy, VV, et al.
Publicerad: (2020)

Surfactant Apoprotein D in Preterm Neonates with Acute Respiratory Distress Syndrome
av: S. A. Perepelitsa, et al.
Publicerad: (2009-10-01)

The Effects of Antenatal Corticosteroids and Surfactant Replacement on Neonatal Respiratory Distress Syndrome
av: Suada Heljić, et al.
Publicerad: (2009-08-01)

Surfactant and respiratory distress syndrome
av: A D Milner
Publicerad: (1996-01-01)

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress
av: Anna Tarocco, et al.
Publicerad: (2015-01-01)

Exogenous surfactant transport through the pulmonary airways : improving surfactant replacement therapy for neonatal respiratory distress syndrome
av: Espinosa, Frank F. (Frank Francis)
Publicerad: (2005)

Corrigendum to “Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress”
av: Anna Tarocco, et al.
Publicerad: (2015-01-01)

Effects of Exogenous Surfactants on the Parameters of Blood Gas Composition in Neonatal Respiratory Distress Syndrome
av: S. A. Perepelitsa, et al.
Publicerad: (2007-06-01)

Replacement Therapy with the Surfactant Alveofact for Neonatal Respiratory Distress Syndrome: A Pilot Study
av: S. A. Perepelitsa
Publicerad: (2014-08-01)

Management of respiratory distress syndrome in moderate/late preterm neonates: A Delphi consensus
av: Segundo Rite Gracia, et al.
Publicerad: (2024-11-01)

Outcomes Comparison of Early versus Late Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome
av: Chutinun Wongkhonkaen, et al.
Publicerad: (2023-05-01)

Clinical efficacy of using pulmonary surfactant at different times in the treatment of neonatal respiratory distress syndrome
av: ZHU Ling, et al.
Publicerad: (2023-12-01)

An uncommon cause of neonatal respiratory distress
av: Gabriel Dimitriou, et al.
Publicerad: (2010-12-01)

Significance of surfactant proteins in respiratory distress syndrome in preterm infants
av: İ.A. Mirzayeva, et al.
Publicerad: (2024-04-01)

Exogenous surfactant therapy in non-respiratory distress syndrome
av: A Greenough
Publicerad: (1996-01-01)

Surfactant BL-Induced Changes in Blood Gas Composition and Acid-Base Balance In Neonatal Respiratory Distress Syndrome
av: S. A. Perepelitsa, et al.
Publicerad: (2006-08-01)

Laryngeal Mask Airway Method for Minimally Invasive Surfactant Therapy in Neonates with Pneumothorax Complicating Respiratory Distress Syndrome
av: Joaquim M. B. Pinheiro, et al.
Publicerad: (2025-01-01)

Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis
av: Moschino, L, et al.
Publicerad: (2022)

Surfactant as a drug carrier
av: Sett, A, et al.
Publicerad: (2023)

Comparison of the Consequences of Intratracheal Administration of Surfactant Plus Budesonide with Surfactant alone in Preterm Infants with Respiratory Distress Syndrome
av: Morteza Habibi, et al.
Publicerad: (2024-01-01)

Guidelines on the management of acute respiratory distress syndrome
av: Danny Francis McAuley, et al.
Publicerad: (2019-10-01)

The Outcomes of Preterm Infants with Neonatal Respiratory Distress Syndrome Treated by Minimally Invasive Surfactant Therapy and Non-Invasive Ventilation
av: Tzyy-Rong Huang, et al.
Publicerad: (2024-04-01)

Respiratory Distress and the Bacteria Causing Infection in the Neonates
av: Neihaya Heikmat Zaki
Publicerad: (2012-06-01)

Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome
av: Nilgün Köksal, et al.
Publicerad: (2009-12-01)

Management of neonates with respiratory distress syndrome in resource-limited settings
av: Radhika Singh, et al.
Publicerad: (2024-05-01)

INSURE method (INtubation-SURfactant-Extubation) in early and late premature neonates with respiratory distress: factors affecting the outcome and survival rate
av: Ali Naseh, et al.
Publicerad: (2014-06-01)

Construction and evaluation of neonatal respiratory failure risk prediction model for neonatal respiratory distress syndrome
av: Yupeng Lei, et al.
Publicerad: (2024-01-01)

Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond
av: Ozge Sürmeli-Onay, et al.
Publicerad: (2012-06-01)

Exogenous Surfactant Therapy for Pediatric Patients with Acute Respiratory Distress Syndrome
av: James F Lewis, et al.
Publicerad: (1997-01-01)

Use of Surfactant-BL in Adult Patients with Acute Respiratory Distress Syndrome
av: A. V. Vlasenko, et al.
Publicerad: (2005-12-01)

Surfactant Protein D Is a Biomarker of Acute Respiratory Distress Syndrome
av: V. V. Moroz, et al.
Publicerad: (2013-08-01)

The association between sex and neonatal respiratory distress syndrome
av: Keren Fang, et al.
Publicerad: (2024-02-01)

Influence of catheter thickness on respiratory physiology during less invasive surfactant administration in extremely preterm infants
av: Chamindu C. Gunatilaka, et al.
Publicerad: (2024-09-01)

Pulmonary insufficiency of extreme prematurity (PIEP) and surfactant deficiency disease (SDD) – It is time to classify respiratory distress syndrome (RDS) in preterm neonates
av: Deepti Thandaveshwara, et al.
Publicerad: (2024-04-01)

Comparing the Effects of Two Surfactant Administration Methods: Minimally Invasive Surfactant Therapy (MIST) with Intubation (INSURE) in Infants with Respiratory Distress Syndrome
av: Hassan Boskabadi, et al.
Publicerad: (2024-10-01)